Identification of B-Cell Linear Epitopes in the Nucleocapsid (N) Protein B-Cell Linear Epitopes Conserved among the Main SARS-CoV-2 Variants
Viruses · 2023
DOI: 10.3390/v15040923 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Rodrigo N Rodrigues-da-Silva und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immunological Technology, Institute of Technology in Immunobiologicals, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. Hauptthemen laut MEDLINE: Common Cold, COVID-19, Middle East Respiratory Syndrome Coronavirus. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Inova Fiocruz/Fundação Oswaldo Cruz, FAPERJ, Inovabio.
Abstract (Originalsprache)
The Nucleocapsid (N) protein is highlighted as the main target for COVID-19 diagnosis by antigen detection due to its abundance in circulation early during infection. However, the effects of the described mutations in the N protein epitopes and the efficacy of antigen testing across SARS-CoV-2 variants remain controversial and poorly understood. Here, we used immunoinformatics to identify five epitopes in the SARS-CoV-2 N protein (N(34–48), N(89–104), N(185–197), N(277–287), and N(378–390)) and validate their reactivity against samples from COVID-19 convalescent patients. All identified epitopes are fully conserved in the main SARS-CoV-2 variants and highly conserved with SARS-CoV. Moreover, the epitopes N(185–197) and N(277–287) are highly conserved with MERS-CoV, while the epitopes N(34–48), N(89–104), N(277–287), and N(378–390) are lowly conserved with common cold coronaviruses (229E, NL63, OC43, HKU1). These data are in accordance with the observed conservation of amino acids recognized by the antibodies 7R98, 7N0R, and 7CR5, which are conserved in the SARS-CoV-2 variants, SARS-CoV and MERS-CoV but lowly conserved in common cold coronaviruses. Therefore, we support the antigen tests as a scalable solution for the population-level diagnosis of SARS-CoV-2, but we highlight the need to verify the cross-reactivity of these tests against the common cold coronaviruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Immunological Technology, Institute of Technology in Immunobiologicals, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
- Eukaryotic Pilot Laboratory, Institute of Technology in Immunobiologicals, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
- Laboratory of Immunoparasitology, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
- Getulio Vargas State Hospital, Rio de Janeiro 21070-061, Brazil.
- SENAI Innovation Institute for Green Chemistry, Rio de Janeiro 20271-030, Brazil.
ORCID-Profile: Rodrigo N Rodrigues-da-Silva, Fernando P Conte, Josué C Lima-Junior
Förderung
- Inova Fiocruz/Fundação Oswaldo Cruz
- FAPERJ
- Inovabio
Zitieren
APA
Rodrigues-da-Silva, R. N., Conte, F. P., da Silva, G., Carneiro-Alencar, A. L., Gomes, P. R., Kuriyama, S. N., Neto, A. A. F., & Lima-Junior, J. C. (2023). Identification of B-Cell Linear Epitopes in the Nucleocapsid (N) Protein B-Cell Linear Epitopes Conserved among the Main SARS-CoV-2 Variants. Viruses. https://doi.org/10.3390/v15040923
Vancouver
Rodrigues-da-Silva RN, Conte FP, da Silva G, Carneiro-Alencar AL, Gomes PR, Kuriyama SN, et al. Identification of B-Cell Linear Epitopes in the Nucleocapsid (N) Protein B-Cell Linear Epitopes Conserved among the Main SARS-CoV-2 Variants. Viruses. 2023. doi:10.3390/v15040923
BibTeX
@article{RodriguesdaSilva2023,
author = {Rodrigues-da-Silva, Rodrigo N and Conte, Fernando P and da Silva, Gustavo and Carneiro-Alencar, Ana L and Gomes, Paula R and Kuriyama, Sergio N and Neto, Antonio A F and Lima-Junior, Josué C},
title = {Identification of B-Cell Linear Epitopes in the Nucleocapsid (N) Protein B-Cell Linear Epitopes Conserved among the Main SARS-CoV-2 Variants},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15040923}
}
EUVIMED